Endo Inc.

Company Snapshot

Founded: 1920
Entity Type: Public
Employees: 3,116
Region: Ireland
Revenue: $1,178.2 Millions
Revenue Year: 2024
Headquarter: DUBLIN, Ireland
Key Geographics: Ireland
Corporate Address: First Floor, Minerva House, Simmonscourt Road, Ballsbridge, Dublin 4 Ireland Tel. 011-353-1-268-2000 www.endo.com

Company Overview

Endo Inc. is a pharmaceutical company that operates in four reportable business segments: International Pharmaceuticals, Generic Pharmaceuticals, Sterile Injectables, and Branded Pharmaceuticals. Through the company’s operating company, Paladin Pharma Inc., its international pharmaceuticals segment offers a range of specialty pharmaceutical products, including over-the-counter (OTC) products, that are sold outside of the U.S., mainly in Canada.

The company is headquartered in the U.S. and has other corporate offices in Ireland and Canada. Four manufacturing facilities are located in the U.S.: Cranbury, N.J.; Horsham, Pa; Rochester, Mich.; and Rye, N.Y. Five manufacturing facilities are situated in India, including Chennai, Mumbai, Dhar, and Alathur.

Financial Highlights (FY 2024)

Net Revenue: ***
Total Current Liabilities: ***
Total Current Assets: ***
R&D expenses: ***
Operating Income: ***

This information is available for BCC Research members only.

Endo Inc. In Reports

Needle-Free Devices: Technologies and Global Markets

BCC Research Market Analyst says global market for needle-free devices was valued at $15.5 billion in 2024 and is estimated to increase from $17.0 billion in 2025 to reach $27.7 billion by 2030.

Global Market for Pain Management Drugs and Devices

BCC Research Market Report says global market for pain management drugs and devices is expected to increase from $84.6 billion in 2023 to $109.9 billion by the end of 2028, with a CAGR of 5.4%.

Transdermal Patches: Global Markets

BCC Research Market Report says transdermal patches is estimated to increase from $6.7 billion in 2022 to reach $8.8 billion by 2027, at a CAGR of 5.6%.

Company's Business Segments

  • Branded Pharmaceuticals : Branded Pharmaceuticals segment includes a variety of branded products in the areas of Urology, Orthopedics, Endocrinology, Bariatrics, among others.
  • Sterile Injectables : Sterile Injectables segment consists primarily of branded Sterile Injectable products such as ADRENALIN, VASOSTRICT, APLISOL, among others, and certain generic sterile injectable products.
  • Generic Pharmaceuticals : Generic Pharmaceuticals segment consists of a product portfolio including solid oral extended-release products, Solid Oral immediate-release products, Liquids, Semi-solids, Patches, Powders, Ophthalmics, Sprays and includes products that treat and manage a wide variety of medical conditions.
  • International Pharmaceuticals : International Pharmaceuticals segment includes a variety of specialty pharmaceutical products, including OTC products, sold outside the U.S., primarily in Canada through our operating company Paladin.

Applications/End User Industries

  • Urology
  • Orthopedics
  • Endocrinology
  • Bariatrics
  • Pharmaceuticals
  • Injectables
  • Hospitals
  • Clinics
  • Healthcare
  • Pharmacies
  • Sterile Injectables
  • Generic Products
  • Ophthalmics
  • OTC Products
AI Sentiment